PNV Polynovo Ltd.
—Mkt Cap: —P/E: —1d ago
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSo…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value414.96M USD
Revenue (TTM)103.56M USD
Gross Profit88.79M USD
Net Income (TTM)5.07M USD
Revenue/Share0.22 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000PNV0
Valuation
P/E (Trailing)—
P/E (Forward)33.24
PEG1.53
EV/EBITDA38.83
EV/Revenue4.01
P/S4.17
P/B6.91
EPS (TTM)0.01
EPS (Forward)0.03
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin89.41%
Oper. Margin14.10%
EBITDA Margin10.32%
Profit Margin5.11%
ROE8.09%
ROA5.56%
Growth
Revenue Growth15.00%
Earnings Growth-25.70%
Cash Flow & Leverage
Operating CF15.97M USD
CapEx (TTM)9.53M USD
FCF Margin-1.22%
FCF Yield—
Net Debt-12.34M USD
Net Debt/EBITDA-1.16
Balance Sheet
Debt/Equity0.19
Current Ratio2.99
Quick Ratio2.59
Book Value/Sh0.13 AUD
Cash/Share0.05 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split0.1429:1
Split DateMay 3, 2004
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.254 AUD
Target Range0.9500 AUD – 1.700 AUD
# Analysts7
Ownership
Shares Out.690.84M
Float601.37M
Insiders9.97%
Institutions31.19%
Technical
SMA 500.9748 AUD
SMA 2000.9957 AUD
Beta1.34
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)861.80K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—